Systematic Financial Management LP Amgen Inc Transaction History

Systematic Financial Management LP

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2019 Feb 14, 2020	SELL	$189.21 - $243.2 $40,490 - $52,044	-214 Closed	0 $0
Q3 2019 Nov 06, 2019	SELL	$174.11 - $208.62 $1.69 Million - $2.02 Million	-9,689 Reduced 97.84%	214 $41,000
Q2 2019 Jul 26, 2019	SELL	$166.7 - $195.41 $305,894 - $358,577	-1,835 Reduced 15.63%	9,903 $1.83 Million
Q1 2019 May 03, 2019	SELL	$180.87 - $203.88 $554,366 - $624,892	-3,065 Reduced 20.71%	11,738 $2.23 Million
Q4 2018 Feb 13, 2019	SELL	$178.4 - $208.25 $381,597 - $445,446	-2,139 Reduced 12.63%	14,803 $2.88 Million
Q3 2018 Nov 06, 2018	SELL	$185.29 - $208.89 $61,886 - $69,769	-334 Reduced 1.93%	16,942 $3.51 Million
Q2 2018 Aug 08, 2018	SELL	$166.05 - $186.51 $27,232 - $30,587	-164 Reduced 0.94%	17,276 $3.19 Million
Q1 2018 May 09, 2018	SELL	$169.43 - $198.0 $15,079 - $17,622	-89 Reduced 0.51%	17,440 $2.97 Million
Q4 2017 Feb 09, 2018	SELL	$168.79 - $188.59 $293,525 - $327,958	-1,739 Reduced 9.03%	17,529 $3.05 Million
Q3 2017 Nov 08, 2017	BUY	$167.29 - $191.0 $3.22 Million - $3.68 Million	19,268	19,268 $3.59 Million

3,122

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $149B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Systematic Financial Management LP, based on Form 13F filings with the SEC.

Stay updated on Systematic Financial Management LP with notifications on news.